Tag: optogenetics market trend

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Optogenetics Industry By 2029?

The expansion of the optogenetics market has been swift in the recent past, escalating from $35.91 billion in 2024 to $40.9 billion in 2025, marking a compound annual growth rate (CAGR) of 13.9%. The remarkable growth during the historical timeframe can be credited to a variety of factors including the surge in neurological disorders, an increase in funding for life sciences, advancements in drug discovery and development, progress in mapping neural circuits, the application of optogenetics in drug screening, and breakthroughs in neurophotonics.

The market for optogenetics is anticipated to experience a swift expansion in the upcoming years, reaching $71.21 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 14.9%. This projected growth during the forecasted period is due to factors like its applications in therapy, clinical trials, and translations, its usage in non-neuronal cells, contributions to brain-machine interfaces, and the creation of new light-sensitive proteins. Key trends during this future period include progress in optogenetic tools and technologies, partnerships with pharmaceutical firms, the use of optogenetics in drug discovery and R&D, expansion to non-neuronal cell types, and merging with other imaging technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

Which Industry Forces Are Driving The Optogenetics Market Forward?

The surge in Parkinson’s disease and epilepsy globally is predicted to stimulate the expansion of the optogenetics market. Parkinson’s disease (PD) can be described as a degenerative brain condition, which triggers motor symptoms like slow motion tremors, stiffness, and imbalance. It is also linked with cognitive decline, mental health disorders, difficulty in sleeping, pain, and sensory disturbances. Epilepsy, another brain disorder, culminates in seizures. The treatment of Parkinson’s disease in optogenetic therapy involves using proteins which react to specific light wavelengths. Gene therapy techniques are used to manufacture these proteins, which are programmed to activate or inactivate when subjected to specific light categories, consequently, normalizing brain function in Parkinson’s disease patients. Data from The Parkinson’s Foundation, a US organization committed to enhancing the lives of those affected by Parkinson’s disease, confirmed a substantial increase in annual Parkinson’s disease diagnosis in December 2022 to almost 90,000, a significant leap from the prior figure of 60,000. Furthermore, the number of individuals in the U.S. living with PD is projected to grow to 1.2 million by 2030 from 930,000 in 2020. Thus, the worldwide rise in Parkinson’s disease and epilepsy incidences are fueling the ascent of the optogenetics market.

What Is The Segment Breakdown Of The Optogenetics Market?

The optogeneticsmarket covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

How Are Global Trends Impacting The Development Of The Optogenetics Market?

Pioneering new systems is a significant trend that has risen in prominence in the optogenetics market. Large-scale businesses in the optogenetics field are constructing state-of-the-art optogenetics tools and systems to keep their market position intact. For example, in June 2022, Bruker Corporation, an American-based creator of optogenetics tools, introduced NeuraLight 3D Ultra, an improved 3D holographic stimulation for optogenetics modules, designed to aid complex neuroscience and optogenetics research on Bruker’s Ultima 2Pplus Multiphoton Microscope. This new innovation delivers advanced 3D holographic photostimulation, specifically tailored to aid in-depth functional research on neural networks and brain computation.

Which Companies Are Contributing Significantly To The Optogenetics Market Growth?

Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Which Region Is Leading Innovation In The Optogenetics Market?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9009&type=smp

Browse Through More Reports Similar to the Global Optogenetics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Tumor Embolization Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Optogenetics Market Growth Performance Trended Historically, And What Lies Ahead?

The market for optogenetics has seen significant expansion in the past few years. Its size is projected to increase from $35.91 billion in 2024 to $40.9 billion in 2025, representing a compound annual growth rate (CAGR) of 13.9%. This historical growth can be attributed to the surge in neurological diseases, increased investments in life sciences and drug discovery and development, advancements in mapping neural circuits, the use of optogenetics in drug screening, and progress in neurophotonics.

In the coming years, the optogenetics market is anticipated to witness significant growth, ballooning to $71.21 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. This projected growth during the forecast period is due to various factors such as its therapeutic uses, clinical testing and translation, broadening its reach to non-neuronal cells, and the application of optogenetics in the development of brain-machine interfaces and new light-sensitive proteins. The forecast period will also see significant trends such as the enhancement of optogenetic tools and techniques, partnerships with pharmaceutical companies, the use of optogenetics in drug discovery and development, the expansion to non-neural cell categories, and its integration with other imaging technologies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOptogenetics Market?

Expectations for the expansion of the optogenetics market are driven by the escalating incidences of conditions like Parkinson’s disease and epilepsy throughout the world. Parkinson’s disease is identified as a degenerative brain disorder that triggers motor symptoms such as slowness of motion, shakes, stiffness, and imbalance alongside issues like cognitive impairment, mental health disorders, sleep difficulties, pain, and sensory disruptions. Similarly, epilepsy is a medical condition of the brain that prompts seizures. Optogenetic therapy, which utilizes proteins responsive to particular light wavelengths to treat Parkinson’s disease, plays a significant role in this scenario. Generated through gene therapy techniques, these proteins either activate or deactivate when exposed to specific light types, ultimately facilitating normal brain functioning in Parkinson’s disease. The Parkinson’s Foundation, a US entity dedicated to ameliorating the lives of those impacted by Parkinson’s disease, reported a drastic increase in yearly Parkinson’s disease diagnoses in December 2022, shooting up to nearly 90,000 from an earlier estimate of 60,000. Furthermore, the population living with Parkinson’s disease in the U.S. is projected to surge from 930,000 in 2020 to 1.2 million by 2030. Thus, the escalating instances of Parkinson’s disease and epilepsy globally are propelling the acceleration of the optogenetics market.

Which Segments in the Optogenetics Offer the Most Growth?

The optogeneticsmarket covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9009&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOptogenetics Market?# Market?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Current Market Growth and Trends in the Optogenetics Industry?

The creation of novel systems is a principal trend gaining traction in the optogenetics market. Main players in the optogenetics sector are fabricating advanced optogenetics tools and systems using state-of-the-art technologies to maintain their market reputation. For instance, in June 2022, Bruker Corporation, an optogenetics tool manufacturer based in the US, rolled out the NeuraLight 3D Ultra, an improved 3D holographic stimulation for optogenetics modules, meant to support complex neuroscience and optogenetics research activities on Bruker’s Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra provides state-of-the-art 3D holographic photostimulation designed for comprehensive functional research on neural networks and brain computation.

View the full report here:

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

What Are the Key Elements That Define the Optogenetics Market?

Optogenetics is a comprehensive technique that uses optical systems and genetic engineering technologies to accurately regulate and monitor the biological processes of a cell, group of cells, tissues, or organ with high temporal and spatial resolution. Optogenetics is to monitor and control the physiological activity of neurons and other cell types that include light sensors frequently employed to identify the underlying causes of ailments such as Parkinson’s, memory illnesses, anxiety, addiction issues, mood swings, and other conditions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9009

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the optogenetics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Milestones in the Optogenetics Market’s Growth Trajectory From 2025 To 2034?_x000D_

In recent years, there has been a swift expansion in the optogenetics market size. Its growth is projected to accelerate from $35.91 billion in 2024 to $41.16 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.6%. Historical growth trends in this market have been influenced by factors such as an increase in neurological disorders, augmented funding in life sciences, advancements in drug discovery and development, developments in neural circuit mapping, the role of optogenetics in drug screening, and progress in neurophotonics._x000D_

_x000D_

Forecasting shows the optogenetics market ballooning in the next few years, with projections pointing to a value of $71.95 billion by 2029, indicating a compound annual growth rate (CAGR) of 15.0%. This predicted growth can be credited to areas like therapeutic applications, clinical translations and trials, extensions into non-neuronal cells, the use of optogenetics in brain-machine interfaces, and the creation of new light-sensitive proteins. Expected trends within this period encompass advancements in optogenetic tools and technologies, forging partnerships with pharmaceutical firms, leveraging optogenetics for drug discovery and development, expanding into non-neural cell sectors, and merging with other imaging technologies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the Optogenetics Market?#_x000D_

The global increase in Parkinson’s disease and epilepsy cases is anticipated to stimulate the expansion of the optogenetics market. Parkinson’s disease (PD) is characterized by a degenerative disorder of the brain that triggers motor symptoms like slow movement shakes, stiffness, and imbalance apart from other problems such as cognitive deterioration, mental health disorders, sleep difficulties, pain, and sensory disturbances. Similarly, epilepsy is a brain disorder that gives rise to seizures. Optogenetic therapy, in which proteins that react to specific light wavelengths are employed to alleviate Parkinson’s disease, can potentially treat these conditions. These proteins can be manufactured using gene therapy methods to either activate or deactivate upon being exposed to precise kinds of light, leading to Parkinson’s disease brain function normalization. For example, The Parkinson’s Foundation, a US organization committed to enhancing the quality of life of those afflicted by Parkinson’s disease, reported in December 2022 that there was a drastic increase in annual Parkinson’s disease diagnoses to nearly 90,000, a significant jump from the formerly estimated 60,000. Additionally, the population of people with PD in the U.S. is predicted to swell to 1.2 million by 2030, a rise from 930,000 in 2020. Therefore, the growth of the optogenetics market is being propelled by the worldwide surge in Parkinson’s disease and epilepsy cases._x000D_

_x000D_

#Which Primary Segments of the Optogenetics Market Are Driving Growth and Industry Transformations?#_x000D_

The optogenetics market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Lasers, Actuators, Sensors_x000D_

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications_x000D_

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers_x000D_

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs_x000D_

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9009&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the Optogenetics Market?#_x000D_

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Most Significant Market Trends in the Optogenetics Market?#_x000D_

In the optogenetics market, the key trend gaining momentum is the creation of innovative systems. Large corporations in this field are focusing on the development of pioneering tools and systems using the most advanced technologies to maintain their market positions. A case in point occurred in June 2022, when Bruker Corporation, a top optogenetics tool producer based in the US, introduced NeuraLight 3D Ultra. This enhanced 3D holographic stimulation for the optogenetics module aids cutting-edge neuroscience and optogenetic research applications on Bruker’s Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra supplies top-tier 3D holographic photostimulation designed specifically for extensive functional research on neural networks and brain computation._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Optogenetics Market?#_x000D_

Optogenetics is a comprehensive technique that uses optical systems and genetic engineering technologies to accurately regulate and monitor the biological processes of a cell, group of cells, tissues, or organ with high temporal and spatial resolution. Optogenetics is to monitor and control the physiological activity of neurons and other cell types that include light sensors frequently employed to identify the underlying causes of ailments such as Parkinson’s, memory illnesses, anxiety, addiction issues, mood swings, and other conditions._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9009_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Optogenetics Market?

The escalating incidences of Parkinson’s disease and epilepsy globally are anticipated to boost the optogenetics market’s expansion. Parkinson’s disease (PD) is characterized as a neurodegenerative disorder causing motor symptoms like slow motion tremors, rigidity, and instability, alongside other issues such as cognitive decline, psychiatric complications, sleep problems, pain, and sensory disruptions. Epilepsy, a neurological condition, leads to seizures. Optogenetic therapy uses light-sensitive proteins to treat Parkinson’s disease. These proteins, activated or deactivated by certain light types, can be generated through gene therapy, ultimately resulting in the stabilization of brain function in Parkinson’s patients. For example, The Parkinson’s Foundation, a USA-based organization committed to enhancing the lives of Parkinson’s patients, reported an abrupt hike in annual diagnoses of Parkinson’s disease to nearly 90,000 in December 2022, a significant increase from the earlier estimate of 60,000. Furthermore, it is predicted that the number of people living with PD in the U.S. will rise to 1.2 million by 2030, amplified from 930,000 in 2020. Therefore, the worldwide surge in Parkinson’s disease and epilepsy cases is propelling the optogenetics market’s progression.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

How Has the Optogenetics Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The market size for optogenetics has experienced swift growth in recent years. The market is projected to rise from $35.91 billion in 2024 to $41.16 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.6%. Factors such as the increase in neurological disorders, heightened investment in life sciences, advancements in drug discovery and development, neural circuit mapping, application of optogenetics in drug screening, and developments in neurophotonics have contributed significantly to growth during the historic period.

In the coming years, the optogenetics market is anticipated to experience swift growth, reaching $71.95 billion in 2029, with a compound annual growth rate (CAGR) of 15.0%. This growth during the forecast period can be ascribed to several factors such as therapeutic applications, clinical trials, translation, expansion into non-neuronal cells, integration of optogenetics in brain-machine interfaces, and the creation of new light-sensitive proteins. The expected trends for the forecast period include progress in optogenetic tools and technologies, partnerships with pharmaceutical firms, the use of optogenetics in drug discovery and development, growth into non-neural cell categories, and the combination with other imaging technologies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9009

What Are the Most Significant Market Trends Transforming theOptogenetics Market?

Innovation in system development is the primary trending feature in the optogenetics market. Top entities in the market are fostering advanced optogenetics tools and systems using state-of-the-art technologies to maintain their market presence. For example, Bruker Corporation, a US firm producing optogenetics tools, introduced NeuraLight 3D Ultra in June 2022. This improved 3D holographic stimulation for optogenetics modules aids advanced neuroscience and optogenetics studies on Bruker’s Ultima 2Pplus Multiphoton Microscope. The NeuraLight 3D Ultra provides groundbreaking 3D holographic photostimulation specially designed for in-depth functional studies on neural networks and brain computation.

What Are the Top Market Players Propelling the Growth of theOptogenetics Industry?

Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

Which Primary Segments of the Optogenetics Market Are Driving Growth and Industry Transformations?

The optogenetics market covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9009&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Optogenetics Market?# Market?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Optogenetics Maret 2025, By The Business Research Company:

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the optogenetics market?

The market size of optogenetics has witnessed considerable growth recently, and it is predicted to inflate further from $35.91 billion in 2024 to $41.16 billion in 2025, maintaining a compound annual growth rate (CAGR) of 14.6%. The significant growth observed in the historic period has been spurred by factors such as the increasing occurrence of neurological disorders, enhanced financing in life sciences, advancements in drug discovery and development, mapping of neural circuits, the association of optogenetics in drug screening, as well as progress in neurophotonics.

What will be the optogenetics market size in the future?

In the coming years, the optogenetics market size is anticipated to witness a swift expansion. It’s set to increase to a size of $71.95 billion by 2029, registering a compound annual growth rate (CAGR) of 15.0%. The projected growth during this period can be linked to factors like therapeutic applications, clinical trials and translation, the adaptation into non-neuronal cells, the use of optogenetics in brain-machine interfaces, and the development of new light-sensitive proteins. The forecast period will also see major trends such as the progress in optogenetic tools and technologies, partnerships with pharmaceutical firms, the use of optogenetics in drug discovery and development, spreading into non-neural cell forms, and combination with other imaging technologies.

Get your optogenetics market report here!

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

What main drivers are fueling expansion in the optogenetics market?

The optogenetics market is predicted to expand as a result of the increasing incidence of Parkinson’s disease and epilepsy globally. Parkinson’s disease, a progressive brain disorder, causes motor problems including shaking, slow movement, stiffness and imbalance, along with other problems like cognitive decline, mental health problems, sleep disturbances, pain and sensory problems. Epilepsy, another brain disorder, leads to seizures. Optogenetic therapy employs proteins that react to certain light wavelengths to treat Parkinson’s disease. These proteins, generated through gene therapy techniques, either activate or deactivate when exposed to specific light types, which can help to restore normal functioning in the brain of patients with Parkinson’s disease. For example, The Parkinson’s Foundation, a U.S.-based organization committed to enhancing the quality of life for those affected by Parkinson’s disease, reported in December 2022 a significant increase in the annual Parkinson’s disease diagnoses, with nearly 90,000 cases, up from the earlier estimate of 60,000. Furthermore, the number of individuals with PD in the U.S. is projected to rise to 1.2 million by 2030 from 930,000 in 2020. Consequently, the escalating numbers of Parkinson’s disease and epilepsy cases worldwide are propelling the optogenetics market.

What key areas define the segmentation of the global optogenetics market?

The optogenetics market covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

Who are the dominant players expanding their reach in the optogenetics market?

Major companies operating in the optogenetics market include Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Danaher Corporation, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Judges Scientific Plc., Merck KGaA, The Jackson Laboratory, Noldus Information Technology BV, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Novartis, AbbVie, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems

How are evolving market trends shaping optogenetics Strategies?

The emergence of pioneering systems is the central trend gaining traction in the optogenetics market. The main players in the optogenetics market are creating innovative tools and systems equipped with advanced technologies to maintain their market standing. For example, in June 2022, Bruker Corporation, an American optogenetics tool production company, introduced the NeuraLight 3D Ultra, an improved 3D holographic stimulation for an optogenetics module. This is designed to support leading-edge neuroscience and optogenetics research applications on Bruker’s Ultima 2Pplus Multiphoton Microscope. NeuraLight 3D Ultra provides state-of-the-art 3D holographic photostimulation, specifically tailored for comprehensive functional research on neural networks and brain computation.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9009

Which regions are emerging as leaders in the optogenetics market?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Optogenetics Market Grow Over the Forecast Period Based on Its Expected CAGR?

The rapid expansion of the optogenetics market has been noticeable in recent years. It is projected that the market value will increase from $35.91 billion in 2024 to $41.16 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.6%. The historical period’s growth is primarily attributed to an increase in neurological disorders, heightened funding in life sciences, progression in drug discovery and development, advancements in mapping neural circuits, the application of optogenetics in drug screening, and progress in neurophotonics.

The size of the optogenetics market is predicted to undergo fast expansion in the upcoming years, reaching $71.95 billion by 2029, at a compound annual growth rate (CAGR) of 15.0%. The increase during this forecast period can be attributed to factors such as its use in therapeutic applications, clinical trials, translation, its expansion into non-neuronal cells, its application in brain-machine interfaces, and the creation of novel light-sensitive proteins. Key trends during this forecast period involve progress in optogenetic tools and technologies, partnerships with pharmaceutical firms, the application of optogenetics in drug discovery and development, expansion into non-neural cell types, and convergence with other imaging technologies.

What Are the Primary Drivers Supporting the Growth of the optogenetics Market?

As the incidence of Parkinson’s disease and epilepsy continues to escalate worldwide, the optogenetics market is anticipated to experience corresponding growth. Parkinson’s disease is a brain degenerative condition marked by motor symptoms such as slowed movements, tremors, stiffness, balance issues, and is often accompanied by cognitive impairment, mental health concerns, sleep problems, pain, and sensory disturbances. Epilepsy is another neurological condition characterized by seizures. Optogenetic therapy uses light-responsive proteins to treat Parkinson’s disease, which can be engineered using gene therapy techniques to activate or deactivate in the presence of specific light types, leading to the restoration of normal brain function in Parkinson’s disease patients. For example, as claimed by The Parkinson’s Foundation, a US organization committed to enhancing the quality of life of individuals living with Parkinson’s disease, there was a significant surge in the annual Parkinson’s disease diagnoses in December 2022, close to 90,000, which is a considerable increase from the earlier estimation of 60,000. Further, the count of individuals dealing with PD in the U.S. is projected to climb to 1.2 million by 2030 from 930,000 in 2020. Consequently, the global uptick in Parkinson’s disease and epilepsy incidence is set to fuel the expansion of the optogenetics market.

Explore Comprehensive Insights Into The Global Optogenetics Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9009&type=smp

Who Are the Dominant Players Expanding Their Reach in the Optogenetics Market?

Major companies operating in the optogenetics market include:

• Elliot Scientific Ltd._x000D_

• Shanghai Laser & Optics Century Co. Ltd._x000D_

• GenSight Biologics_x000D_

• Danaher Corporation_x000D_

• Coherent Inc._x000D_

What Are the Top Trends Shaping the Evolution of the Optogenetics Market?

In the optogenetics market, the principal emerging trend is the creation of cutting-edge systems. Major players in the optogenetics industry are investing in the development of cutting-edge optogenetics systems and tools to secure their market presence. To illustrate, in June 2022, Bruker Corporation, a leading optogenetics tool supplier based in the US, unveiled the NeuraLight 3D Ultra. This enhanced 3D holographic stimulator for optogenetics modules was designed to aid advanced neuroscience and optogenetics research on Bruker’s Ultima 2Pplus Multiphoton Microscope. The NeuraLight 3D Ultra provides state-of-the-art 3D holographic photostimulation customized for comprehensive functional research on neural networks and brain computation.

Secure Your Global Optogenetics Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report

What Are the Core Segments of the Optogenetics Market, and How Do They Contribute to Growth?

The optogenetics market covered in this report is segmented –

1) By Product: Lasers, Actuators, Sensors

2) By Application: Neuroscience, Behavioral Tracking, Retinal Disease Treatment, Other Applications

3) By End User: Hospitals And Clinics, Diagnostics Centers, Research Centers, Other End Users

Subsegments:

1) By Lasers: Continuous Wave Lasers, Pulsed Lasers, Fiber-Coupled Lasers

2) By Actuators: Channelrhodopsins, Halorhodopsins, Opto-xRs

3) By Sensors: Calcium Sensors, Voltage Sensors, Genetically Encoded Indicators

Which Regions Are Setting the Pace for Optogenetics Market Growth?

North America was the largest region in the optogenetics market in 2024. The regions covered in the optogenetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Optogenetics Market Defined Across Different Regions?

Optogenetics is a comprehensive technique that uses optical systems and genetic engineering technologies to accurately regulate and monitor the biological processes of a cell, group of cells, tissues, or organ with high temporal and spatial resolution. Optogenetics is to monitor and control the physiological activity of neurons and other cell types that include light sensors frequently employed to identify the underlying causes of ailments such as Parkinson’s, memory illnesses, anxiety, addiction issues, mood swings, and other conditions.

Browse Through More Similar Reports By The Business Research Company:

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

NGS-Based RNA-Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Tumor Embolization Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: